Buflomedil is a vasoactive drug used to treat claudication or the symptoms of peripheral arterial disease. It is currently not approved by the Food and Drug Administration (FDA) for use in the United States. Toxicity This drug might be suspended from marketing in the European Union, because of concerns about severe neurological and cardiac toxicity